GL1X · GenesisL1 explorer

UniProt P60900

Proteasome subunit alpha type-6 (P60900)

Proteasome subunit alpha type-6 (UniProt P60900), EC 3.4.25.1: 145 experimental structures and 1 predicted model on GenesisL1, 4 ligands bound, 472 pockets. Binding sites, druggability and experiment against prediction (TM-score)…

UniProt
P60900
Protein
Proteasome subunit alpha type-6
EC
3.4.25.1
Experimental structures
145
Predicted models
1
Ligands
4
Pockets
472 · 127 records with a druggable one

Structures

146 records of P60900 in the MolNFT archive: 145 experimental, 1 predicted.

EntryTitleMethodChainsLigandsPockets
4R3OHuman Constitutive 20S Proteasomex-ray diffractionA, O—6 (best 0.79)
4R3OHuman constitutive 20S proteasomex-ray diffractionA, O—6 (best 0.79)
4R67Human constitutive 20S proteasome in complex with carfilzomibx-ray diffractionA, O, c, q—5 (best 0.78)
4R67Human constitutive 20S proteasome in complex with carfilzomibx-ray diffractionA, O, c, q—5 (best 0.78)
5A0QCryo-EM reveals the conformation of a substrate analogue in the human 20S proteasome coreelectron microscopyA, O—1 (best 0.69)
5GJQStructure of the human 26S proteasome bound to USP14-ubalelectron microscopyB, h—3 (best 0.80)
5GJRAn atomic structure of the human 26S proteasomeelectron microscopyB, h—1 (best 0.84)
5L4GThe human 26S proteasome at 3.9 Aelectron microscopyN, A—4 (best 0.75)
5LE5Native human 20S proteasome at 1.8 Angstromx-ray diffractionG, UCL, K6 (best 0.77)
5LE5Native human 20S proteasome at 1.8 ångströmx-ray diffractionG, UCL, K6 (best 0.77)
5LEXNative human 20S proteasome in Mg-Acetate at 2.2 Angstromx-ray diffractionG, UK6 (best 0.75)
5LEXNative human 20S proteasome in mg-acetate at 2.2 ångströmx-ray diffractionG, UK6 (best 0.75)
5LEYHuman 20S proteasome complex with Oprozomib at 1.9 Angstromx-ray diffractionG, UCL, K6 (best 0.78)
5LEYHuman 20S proteasome complex with oprozomib at 1.9 ångströmx-ray diffractionG, UCL, K6 (best 0.78)
5LEZHuman 20S proteasome complex with Oprozomib in Mg-Acetate at 2.2 Angstromx-ray diffractionG, UK6 (best 0.77)
5LEZHuman 20S proteasome complex with oprozomib in mg-acetate at 2.2 ångströmx-ray diffractionG, UK6 (best 0.77)
5LF0Human 20S proteasome complex with Epoxomicin at 2.4 Angstromx-ray diffractionG, UCL, K6 (best 0.76)
5LF0Human 20S proteasome complex with epoxomicin at 2.4 ångströmx-ray diffractionG, UCL, K6 (best 0.76)
5LF1Human 20S proteasome complex with Dihydroeponemycin at 2.0 Angstromx-ray diffractionG, UCL, K6 (best 0.77)
5LF1Human 20S proteasome complex with dihydroeponemycin at 2.0 ångströmx-ray diffractionG, UCL, K6 (best 0.77)
5LF3Human 20S proteasome complex with Bortezomib at 2.1 Angstromx-ray diffractionG, UCL, K6 (best 0.76)
5LF3Human 20S proteasome complex with bortezomib at 2.1 ångströmx-ray diffractionG, UCL, K6 (best 0.76)
5LF4Human 20S proteasome complex with Delanzomib at 2.0 Angstromx-ray diffractionG, UCL, K5 (best 0.76)
5LF4Human 20S proteasome complex with delanzomib at 2.0 ångströmx-ray diffractionG, UCL, K5 (best 0.76)
5LF6Human 20S proteasome complex with Z-LLY-ketoaldehyde at 2.1 Angstromx-ray diffractionG, UCL, K, NEN6 (best 0.78)
5LF6Human 20S proteasome complex with Z-lly-ketoaldehyde at 2.1 ångströmx-ray diffractionG, UCL, K6 (best 0.77)
5LF7Human 20S proteasome complex with Ixazomib at 2.0 Angstromx-ray diffractionG, UCL, K5 (best 0.76)
5LF7Human 20S proteasome complex with ixazomib at 2.0 ångströmx-ray diffractionG, UCL, K5 (best 0.76)
5LN3The human 26S Proteasome at 6.8 Ang.electron microscopyA—1 (best 0.79)
5LN3The human 26S proteasome at 6.8 ang.electron microscopyA—1 (best 0.79)
5M32Human 26S proteasome in complex with Oprozomibelectron microscopyG, U—4 (best 0.78)
5M32Human 26S proteasome in complex with oprozomibelectron microscopyG, U—4 (best 0.78)
5T0CStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyAG, BG—2 (best 0.83)
5T0GStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.84)
5T0GStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.84)
5T0HStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.81)
5T0HStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.81)
5T0IStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—2 (best 0.85)
5T0IStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—2 (best 0.85)
5T0JStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.85)
5T0JStructural basis for dynamic regulation of the human 26S proteasomeelectron microscopyG—1 (best 0.85)
5VFONucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—5 (best 0.79)
5VFONucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyG, g—5 (best 0.79)
5VFPNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—2 (best 0.84)
5VFQNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—1 (best 0.80)
5VFRNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—2 (best 0.79)
5VFRNucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyG, g—2 (best 0.79)
5VFSNucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—3 (best 0.86)
5VFTNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—2 (best 0.79)
5VFTNucleotide-driven triple-state remodeling of the aaa-ATPase channel in the activated human 26S…electron microscopyG, g—2 (best 0.79)
5VFUNucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S…electron microscopyG, g—1 (best 0.79)
6AVOCryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively…electron microscopyK, R—4 (best 0.78)
6AVOCryo-EM structure of human immunoproteasome with a novel noncompetitive inhibitor that selectively…electron microscopyK, R—4 (best 0.78)
6E5BHuman Immunoproteasome 20S particle in complex with compound 1x-ray diffractionG, UNA3 (best 0.77)
6E5BHuman immunoproteasome 20S particle in complex with compound 1x-ray diffractionG, UNA3 (best 0.77)
6KWYhuman PA200-20S complexelectron microscopyG, U—5 (best 0.85)
6KWYHuman PA200-20S complexelectron microscopyG, U——
6MSBCryo-EM structures and dynamics of substrate-engaged human 26S proteasomeelectron microscopyG, g—2 (best 0.79)
6MSDCryo-EM structures and dynamics of substrate-engaged human 26S proteasomeelectron microscopyG, g—2 (best 0.83)
6MSECryo-EM structures and dynamics of substrate-engaged human 26S proteasomeelectron microscopyG, g—2 (best 0.83)

86 records more on the page itself.

Ligands

  • K · Potassium ion · in 23 records
  • CL · Chloride ion · in 17 records
  • NA · Sodium ion · in 6 records
  • NEN · 1-ethyl-pyrrolidine-2,5-dione · in 1 record

Experiment against prediction

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.